Synthesis and In Vitro Study of Antiviral Activity of Glycyrrhizin Nicotinate Derivatives against HIV-1 Pseudoviruses and SARS-CoV-2 Viruses › Research Explorer

Novosibirsk State University's Research Portal

Synthesis and In Vitro Study of Antiviral Activity of Glycyrrhizin Nicotinate Derivatives against HIV-1 Pseudoviruses and SARS-CoV-2 Viruses

Research output: Contribution to journal › Article › peer-review

Department of Natural Sciences

DOI

https://doi.org/10.3390/molecules27010295
Final published version

Vladislav V. Fomenko
Nadezhda B. Rudometova
Olga I. Yarovaya
Artem D. Rogachev
Anastasia A. Fando
Anna V. Zaykovskaya
Nina I. Komarova
Dmitry N. Shcherbakov
Oleg V. Pyankov
Andrey G. Pokrovsky
Larisa I. Karpenko
Rinat A. Maksyutov
Nariman F. Salakhutdinov

Original language	English
Article number	295
Journal	Molecules
Volume	27
Issue number	1
DOIs	https://doi.org/10.3390/molecules27010295
Publication status	Published - 1 Jan 2022

Research areas

Entry inhibitors, Human immunodeficiency virus type 1, Nicotinates of glycyrrhizic acid, SARS-CoV-2, Chlorocebus aethiops, COVID-19/drug therapy, Antiviral Agents/chemical synthesis, Glycyrrhizic Acid/chemistry, Humans, SARS-CoV-2/drug effects, HIV Infections/drug therapy, HIV-1/drug effects, Animals, Virus Replication, HeLa Cells, In Vitro Techniques, Vero Cells

OECD FOS+WOS

3.01 BASIC MEDICAL RESEARCH
1.04 CHEMICAL SCIENCES

ID: 35167213